Making good decisions about COVID-19
The COVID-19 pandemic isn't just a challenge for medicine, it's a challenge for decision making of all types
With the COVID-19 pandemic entering its second year, the challenges faced both by individuals and nations remain substantial. While notable medical advancements in the treatment of COVID-19 have been made, a host of questions about how to live with it and how to work to end it remain active.
Carnegie Mellon University researchers David Rode and Paul Fischbeck explore these questions in a new article, "On ambiguity reduction and the role of decision analysis during the pandemic," published in a special issue of the journal END
Carnegie Mellon University researchers David Rode and Paul Fischbeck explore these questions in a new article, "On ambiguity reduction and the role of decision analysis during the pandemic," published in a special issue of the journal END